Abbisko Cayman Limited (HKG:2256)

Hong Kong · Delayed Price · Currency is HKD

12.45

+0.54 (4.53%)

At close: Mar 27, 2026

Revenue by Segment

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019
Development of Innovative Medicines	612.12M	503.99M	19.06M		22.68M		3.84M
Development of Innovative Medicines Growth	21.45%	2544.24%	-		-		-
Total	612.12M	503.99M	19.06M		22.68M		3.84M
Total Growth	21.45%	2544.24%	-		-		-

Revenue by Geography

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019
Mainland China	612.12M	503.99M	19.06M		22.68M		3.84M
Mainland China Growth	21.45%	2544.24%	-		-		-
Total	612.12M	503.99M	19.06M		22.68M		3.84M
Total Growth	21.45%	2544.24%	-		-		-

Source: S&P Global Market Intelligence.